本页面由Tiger Trade Technology Pte. Ltd.提供服务

Alterity Therapeutics Limited

4.58
-0.0899-1.93%
成交量:2,847
成交额:1.32万
市值:8,301.75万
市盈率:-6.93
高:4.65
开:4.65
低:4.58
收:4.67
52周最高:5.89
52周最低:2.66
股本:1,812.57万
流通股本:1,440.25万
量比:0.89
换手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.6613
每股收益(LYR):-0.7470
净资产收益率:-47.02%
总资产收益率:-32.54%
市净率:2.14
市盈率(LYR):-6.13

数据加载中...

2025/08/29

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/09/26

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/31

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/07/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/03/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/07/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/04

SEC问询函

CORRESP [Cover] - Correspondence
2020/12/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/11/25

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/26

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/07/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership